Navigation Links
Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs
Date:4/2/2008

MOUNT PROSPECT, Ill., April 2, 2008 /PRNewswire-USNewswire/ -- The following is being released by the National Association of Boards of Pharmacy:

Ordering prescription drugs online can be safe and convenient when patients use legitimate online pharmacies, but it is all too easy for patients to find themselves the recipients of counterfeit drugs from dishonest Web sites. The vast number of Web sites offering prescription drugs puts patients in "buyer beware" situations as it is often difficult for them to know if the site they are buying from is legitimate. While obtaining drugs from Internet sites that do not require prescriptions or other standard safety measures may be convenient for consumers, it can also be deadly.

According to the World Health Organization, counterfeit drug sales are expected to reach $75 billion globally in 2010, an increase of more than 90% from 2005 -- and the Internet is one of the largest contributors to the distribution of counterfeit drugs to individual consumers. Those especially at risk are people searching for medications at lower prices, seeking lifestyle drugs perceived to be embarrassing, and purposely looking for unauthorized treatment; however, all consumers purchasing drugs from unknown online drug distributors are at risk.

In an effort to protect its citizens from unscrupulous Web sites pretending to be legitimate Internet pharmacies, the state of Indiana passed legislation to help prevent such sites from doing business in its state. Governor Mitch Daniels signed into law Senate Bill 302, which, among other things, requires nonresident pharmacies utilizing the Internet to obtain VIPPS(R) (Verified Internet Pharmacy Practice Sites(TM)) accreditation from the National Association of Boards of Pharmacy(R) (NABP(R)), or an equivalent program approved by the Indiana Board of Pharmacy, before shipping drugs into Indiana. The new law affects those nonresident pharmacies that dispense more than 25% of
'/>"/>

SOURCE National Association of Boards of Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
2. EPA: Nine Indiana Counties Now Meet the Health Standard for Smog
3. Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign
4. Indiana Legislature Should Protect All Workers from Secondhand Smoke
5. Tobacco-Free Kids Indiana Action Fund Launches Campaign in Support of Angela Mansfield and Scott Keller for Indianapolis City-County Council
6. Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. EPA Awards Grant to American Lung Association of Indiana for Community Environmental Health Initiative
8. Medco to Build Worlds Largest, Most Advanced Automated Pharmacy in Central Indiana
9. Anthem Blue Cross and Blue Shield in Indiana Releases State Health Index
10. Brown Mackie College - Indianapolis Announces New Degree Program in Occupational Therapy
11. HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 1Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 2Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 3Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 1Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 2Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 3